NASDAQ:ICUCW SeaStar Medical Earnings Date & Estimates $0.01 +0.00 (+16.98%) As of 01:48 PM Eastern This is a fair market value price provided by Massive. Learn more. SeaStar Medical is estimated to report earnings on Wednesday, November 11, 2026, after market closes. Research:Profile Upcoming Earnings Announcement Announcement DateNovember 11, 2026TimeAfter Market Closes Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from SeaStar MedicalSeaStar Medical is expected to post earnings of -$0.95 per share on revenue of $500 thousand.Consensus EstimatesConsensus EPS-$0.95Expected Revenue$500 thousandPrepare for the Earnings CallCompany Profile SeaStar Medical Earnings FAQ When does SeaStar Medical report earnings? SeaStar Medical (NASDAQ:ICUCW) is estimated to report earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for SeaStar Medical? Analysts expect SeaStar Medical to post earnings of -$0.95 per share for the quarter. How much revenue is SeaStar Medical expected to report? The consensus revenue estimate for SeaStar Medical is $500 thousand for the quarter. SeaStar Medical Earnings HeadlinesSeaStar Medical (ICUCW) Set to Announce Quarterly Earnings on WednesdayNovember 7 at 6:13 AM | americanbankingnews.comSeaStar Medical Earnings Call Shows Growth Amid RisksMay 14, 2026 | tipranks.comSee More SeaStar Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like SeaStar Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SeaStar Medical and other key companies, straight to your email. Email Address About SeaStar MedicalSeaStar Medical (NASDAQ:ICUCW) is a medical technology company developing extracorporeal therapies intended to address harmful immune responses associated with critical illness and organ injury. Its Selective Cytopheretic Device (SCD) is designed to interact with activated immune cells in a patient’s blood during treatment outside the body. The company’s QUELIMMUNE device is intended for use in certain pediatric patients with acute kidney injury and sepsis who require renal replacement therapy. SeaStar Medical is also pursuing development of its technology for additional patient groups and conditions.View SeaStar Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles DraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Wall Street May Be Making a Big Mistake With monday.com StockCloudflare's 20% Sell-Off May Have Created an Opening for InvestorsMarketBeat Week in Review – 11/2 - 11/6 Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
